Daily Archives: July 19, 2011

Real world challenges to deploying effective HIV prevention and treatment

By on .

There was some consensus among the Tuesday opening plenary speakers at the 2011 International AIDS Conference in Rome – there are many challenges to effective HIV prevention and antiretroviral therapy (ART) deployment.

Dr. Peter Piot, of the London School of Hygiene and Tropical Medicine, discussed the AIDS response and the need for a long-term view. In terms of the exciting prevention science released in the recent months, “If we had had these tools ten years or even five years ago when AIDS budgets were expanding and AIDS leadership was at an all time high, I think we would see far less AIDS deaths and far fewer people living with AIDS than we see today.”…

IAS 2011: Where we go from here

By on .

Dr. Anthony Fauci speaks out on treatment as prevention, pre-exposure prophylaxis and the way forward

More details were fleshed out on several compelling studies finding antiretroviral treatment is effective in preventing HIV infection – two pre-exposure prophylaxis studies as well as a large study (HPTN 052) looking at treatment of HIV infected persons in stable discordant partnerships that showed significant protection for the uninfected partner.

Science Speaks addressed these new studies and other topics Monday evening with Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, Dr. Anthony Fauci at the 2011 International AIDS Society meeting in Rome.

HIV and TB Co-Infection: A Perfect Storm

By on .

Alberto Matteeli of Italy began his presentation on HIV and tuberculosis (TB) by reminding his audience that in the pre-antiretroviral therapy (ART) era in Europe and the United States, there were serious outbreaks of drug-resistant tuberculosis, and these outbreaks ceased when ART was scaled up in those settings.  There are currently HIV-associated epidemics of multi-drug […]

HPTN 052 “treatment is prevention” study team releases new details

By on .

The presentation of the detailed findings of HPTN 052 by Dr. Myron Cohen, the study’s principal investigator, and his colleagues was greeted with a standing ovation by a packed room at the 2011 International AIDS Conference in Rome on Monday. The stunning finding of a more than 96 percent reduction in transmission risk for discordant couples where the HIV-infected partner was randomized to early antiretroviral therapy (ART) at CD4 counts of 350-550 compared to couples where ART was delayed for the infected partners until CD4 counts dropped to 250 or less, makes ART the most effective prevention intervention identified to date…

IAS 2011 Coverage: Pediatric HIV/AIDS Highlighted on First Day of Conference

By on .

In this guest blog post by Robert Yule of the Elizabeth Glaser Pediatric AIDS Foundation, various sessions on children and HIV and prevention of mother-to-child transmission (PMTCT) are reviewed, including the role of the community in prevention new infections in infants and children plus keeping mothers healthy, the challenges in developing and purchasing new pediatric formulations of antiretrovirals, and the operational and implementation challenges to scaling up PMTCT…